주요업적

1. Koh SH, Choi SH, Jeong JH, Jang JW, Park KW, Kim EJ, Kim HJ, Hong JY, YoonSJ, Yoon B, Kang JH, Lee JM, Park HH, Ha J, Suh YJ, Kang S. Telomere shortening reflecting physical aging is associated with cognitive decline and dementia conversion in mild cognitive impairment due to Alzheimer's disease. Aging (Albany NY). 2020 Mar3;12(5):4407-4423.

2. Hameed S, Fuh JL, Senanarong V, Ebenezer EGM, Looi I, Dominguez JC, Park KW, Karanam AK, Simon O. Role of Fluid Biomarkers and PET Imaging in Early Diagnosis and its Clinical Implication in the Management of Alzheimer's Disease. J Alzheimers Dis Rep. 2020 Feb 12;4(1):21-37.

3. Yoon B, Choi SH, Jeong JH, Park KW, Kim EJ, Hwang J, Jang JW, Kim HJ, Hong JY, Lee JM, Kang JH, Yoon SJ. Balance and Mobility Performance Along the Alzheimer's Disease Spectrum. J Alzheimers Dis. 2020;73(2):633-644.

4. Kim A, Kim S, Park KW, Park KH, Youn YC, Lee DW, Lee JY, Lee JH, Jeong JH, Choi SH, Han HJ, Kim S, Na S, Park M, Yim HW, Yang DW. Reliability and Validity of a Short Form of the Korean Dementia Screening Questionnaire-Cognition. J Clin Neurol. 2020 Jan;16(1):145-153

5. Kim SE, Lee B, Park S, Cho SH, Kim SJ, Kim Y, JangH, Jeong JH, Yoon SJ, Park KW, Kim EJ, Jung NY, Yoon B, Jang JW, Hong JY, Hwang J, Na DL, Seo SW, Choi SH, Kim HJ. Clinical significance of focal ß-amyloid deposition measured by (18)F-flutemetamol PET. Alzheimers Res Ther. 2020 Jan 4;12(1):6.

6. Ryu SY, Kim A, Kim S, Park KW, Park KH, Youn YC, Lee DW, Lee JY, Lee JH, Jeong JH, Choi SH, Han HJ, Kim S, Na S, Park M, Yim HW, Yang DW. Self- and informant-reported cognitive functioning and awareness in subjective cognitive  decline, mild cognitive impairment, and very mild Alzheimer disease. Int J Geriatr Psychiatry. 2020 Jan;35(1):91-98.

7. Han HJ, Kim BC, Youn YC, Jeong JH, Kim JH, Lee JH, Park KH, Park KW, Kim EJ, Oh MS, Shim YS, Park HY, Yoon B, Yoon SJ, Cho SJ, Park KC, Na DL, Park SA, Lee JM, Choi SH. A Comparison Study of Cilostazol and Aspirin on Changes in Volume of Cerebral Small Vessel Disease White Matter Changes: Protocol of a Multicenter, Randomized Controlled Trial. Dement Neurocogn Disord. 2019 Dec;18(4):138-148.

8. Kim JY, Lim JH, Jeong YJ, Kang DY, Park KW. The Effect of Clinical Characteristics and Subtypes on Amyloid Positivity in Patients with Amnestic Mild Cognitive Impairment. Dement Neurocogn Disord. 2019 Dec;18(4):130-137.

9. Lee HJ, Lee M, Park H, Park JH, Park KW. The Effect of Multi-tasking Exercise Intervention on Cognitive Function in Elderly and Cognitive Impairment Patients:  a Pilot Multicenter Study. Dement Neurocogn Disord. 2019 Dec;18(4):122-129.

10. Kang MJ, Kim SY, Na DL, Kim BC, Yang DW, Kim EJ, Na HR, Han HJ, Lee JH, Kim JH, Park KH, Park KW, Han SH, Kim SY, Yoon SJ, Yoon B, Seo SW, Moon SY, Yang Y, Shim YS, Baek MJ, Jeong JH, Choi SH, Youn YC. Prediction of cognitive impairment  via deep learning trained with multi-center neuropsychological test data. BMC Med Inform Decis Mak. 2019 Nov 21;19(1):231.

11. Jeong J, Jeong YJ, Park KW, Kang DY. Cerebral Amyloid Quantification in Cognitively Normal Korean Adults Using F-18 Florbetaben PET. Nucl Med Mol Imaging. 2019 Oct;53(5):334-339.

12. Jeong J, Jeong YJ, Park KW, Kang DY. Correlation of Early-Phase F-18Florapronal PET with F-18 FDG PET in Alzheimer's Disease and Normal Brain. Nucl Med Mol Imaging. 2019Oct;53(5):328-333.

13. Choi KY, Lee JJ, Gunasekaran TI, Kang S, Lee W, Jeong J, Lim HJ, Zhang X, Zhu C, Won SY, Choi YY, Seo EH, Lee SC, Gim J, Chung JY, Chong A, Byun MS, Seo S, Ko PW, Han JW, McLean C, Farrell J, Lunetta KL, Miyashita A, Hara N, Won S, Choi SM, Ha JM, Jeong JH, Kuwano R, Song MK, An SSA, Lee YM, Park KW, Lee HW, Choi SH, Rhee S, SongWK, Lee JS, Mayeux R, Haines JL, Pericak-Vance MA, Choo ILH, Nho K, Kim KW, Lee DY, Kim S, Kim BC, Kim H, Jun GR, Schellenberg GD, Ikeuchi T, Farrer LA, Lee KH, Neuroimaging Initative AD. APOE Promoter Polymorphism-219T/G is an EffectModifier of the Influence of APOE ε4 on Alzheimer's Disease Risk in aMultiracial Sample. J Clin Med. 2019 Aug 16;8(8). pii: E1236.

14. Lee YK, Gwak BC, Lim JH, Park KW. Osmotic Demyelination Syndrome Presenting with Emotional Incontinence. J Korean Neurol Assoc. 2019 Aug;37(3):304-306.

15. Park J, Kim SE, Kim EJ, Lee BI, Jeong JH, Na HR, Choi SH, Kang DY, Park KW. Effect of 12-week home-based cognitive training on cognitive function and brain metabolism in patients with amnestic mild cognitive impairment. Clin Interv Aging. 2019 Jun 28;14:1167-1175.

16. Park H, Park JH, Na HR, Hiroyuki S, Kim GM, Jung MK, Kim WK, Park KW. Combined Intervention of Physical Activity, Aerobic Exercise, and Cognitive Exercise Intervention to Prevent Cognitive Decline for Patients with Mild Cognitive Impairment: A Randomized Controlled Clinical Study. J Clin Med. 2019 Jun 28;8(7).

17. Lee SJ, Kim H, Kim LS, Kim JH, Park KW. Effects of frontal-executive dysfunction on self-perceived hearing handicap in the elderly with mild cognitive impairment. PLoS One. 2019 Mar 6;14(3):e0210014.

18. Park KW, Hong YJ, Park JH, Park H, Cheon SM, Kim JW, Kim BC, Jeong YJ, Yoon HJ, Kang DY. Pattern of cerebral hypoperfusion according to the clinical staging in dementia with Lewy bodies. Neurocase. 2018 Apr;24(2):83-89

19. Jong-Hwan Park, Hyuntae Park, Sang Wuk Sohn, Sungjae Kim, Kyung Won Park. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer’s dementia. Geriatr Gerontol Int. 2017 Oct;17(10):1603-1609.

20. Hee Kyung Park*, Kee Hyung Park*, Bora Yoon, Jae-Hong Lee, Seong Hye Choi, Jee H Joung, Soo Jin Yoon, Byeong C. Kim, Seung Hyun Kim, Eun-Joo Kim, Duk L. Na, Kyung Won Park. Clinical Characteristics of Parkinsonism in Frontotemporal Dementia according to subtypes. J Neurol Sci. 2017 Jan. 372:51-56.